Richard Mathews
About Richard Mathews
Richard Mathews is the Cellular Therapy Laboratory Manager at NYU Langone Health, with prior experience at Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and Johns Hopkins Hospital.
Title
Richard Mathews holds the position of Cellular Therapy Laboratory Manager at NYU Langone Health. He has been serving in this role since 2020.
Current Role at NYU Langone Health
Richard Mathews has been employed at NYU Langone Health as the Cellular Therapy Laboratory Manager since 2020. In this role, he oversees operations within the Cellular Therapy Lab, ensuring compliance with regulatory standards and optimizing lab processes to support advanced cellular therapy research and treatments.
Previous Work at Massachusetts General Hospital
Prior to his current position, Richard Mathews worked at Massachusetts General Hospital as the Technical Director of the Cellular Therapy Lab from 2013 to 2020, a tenure of seven years. Based in the Greater Boston Area, he was responsible for overseeing the technical aspects of the lab and ensuring the accuracy and efficiency of cellular therapy procedures.
Experience at Memorial Sloan-Kettering Cancer Center
From 2010 to 2013, Richard Mathews served as a Cellular Therapy Technologist at Memorial Sloan-Kettering Cancer Center in the Greater New York City Area. During his three-year tenure, he worked on various cellular therapy techniques and contributed to the advancement of cancer treatment through cellular therapy innovations.
Early Career at Johns Hopkins Hospital
In his early career, Richard Mathews was employed as a Blood Bank Technologist at Johns Hopkins Hospital from 2007 to 2010. Residing in the Baltimore, Maryland Area, he was tasked with managing blood bank operations, ensuring the safety and availability of blood for transfusions, and conducting compatibility testing.
Education and Expertise
Richard Mathews completed his Bachelor's degree in Medical Technology at the State University of New York at Buffalo, where he studied from 2003 to 2007. His academic background and expertise laid the foundation for his extensive career in cellular therapy and blood banking.